
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, et al.
BMJ (2022), pp. e069761-e069761
Open Access | Times Cited: 581
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, et al.
BMJ (2022), pp. e069761-e069761
Open Access | Times Cited: 581
Showing 26-50 of 581 citing articles:
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Severity of the Omicron SARS‐CoV ‐2 variant compared with the previous lineages: A systematic review
Maryam Arabi, Yousef Al‐Najjar, Nada Mhaimeed, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 11, pp. 1443-1464
Open Access | Times Cited: 51
Maryam Arabi, Yousef Al‐Najjar, Nada Mhaimeed, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 11, pp. 1443-1464
Open Access | Times Cited: 51
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China
Jianpeng Cai, Ke Lin, Haocheng Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 48
Jianpeng Cai, Ke Lin, Haocheng Zhang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 48
SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control
José L. Gonzáles, Denise A. Marston
EFSA Journal (2023) Vol. 21, Iss. 2
Open Access | Times Cited: 45
José L. Gonzáles, Denise A. Marston
EFSA Journal (2023) Vol. 21, Iss. 2
Open Access | Times Cited: 45
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications
Núria Mercadé‐Besora, Xintong Li, Raivo Kolde, et al.
Heart (2024), pp. heartjnl-323483
Open Access | Times Cited: 22
Núria Mercadé‐Besora, Xintong Li, Raivo Kolde, et al.
Heart (2024), pp. heartjnl-323483
Open Access | Times Cited: 22
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity
Zemin Yang, Bryan A. Johnson, Victoria Meliopoulos, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113965-113965
Open Access | Times Cited: 22
Zemin Yang, Bryan A. Johnson, Victoria Meliopoulos, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113965-113965
Open Access | Times Cited: 22
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults
Diya Surie, Katharine A. Yuengling, Jennifer DeCuir, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e244954-e244954
Open Access | Times Cited: 22
Diya Surie, Katharine A. Yuengling, Jennifer DeCuir, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e244954-e244954
Open Access | Times Cited: 22
Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study
Olivia Man, Tamiris Azamor, Mary Catherine Cambou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Olivia Man, Tamiris Azamor, Mary Catherine Cambou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Case-only analysis of routine surveillance data: detection of increased vaccine breakthrough infections with SARS-CoV-2 variants in Europe
Jeremy Brown, Piers Mook, Maarten Vanhaverbeke, et al.
Epidemiology and Infection (2025), pp. 1-18
Open Access | Times Cited: 1
Jeremy Brown, Piers Mook, Maarten Vanhaverbeke, et al.
Epidemiology and Infection (2025), pp. 1-18
Open Access | Times Cited: 1
Outcome of infection with omicron SARS‐CoV ‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Ola Blennow, Jon Salmanton‐García, Piotr Nowak, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 8
Open Access | Times Cited: 65
Ola Blennow, Jon Salmanton‐García, Piotr Nowak, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 8
Open Access | Times Cited: 65
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022
Xinhua Chen, Xuemei Yan, Kaiyuan Sun, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2800-2807
Open Access | Times Cited: 64
Xinhua Chen, Xuemei Yan, Kaiyuan Sun, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2800-2807
Open Access | Times Cited: 64
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections
Winnie W. Y. Tso, Mike Yat Wah Kwan, Yu Liang Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1742-1750
Open Access | Times Cited: 56
Winnie W. Y. Tso, Mike Yat Wah Kwan, Yu Liang Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1742-1750
Open Access | Times Cited: 56
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Elsie Horne, William Hulme, Ruth H. Keogh, et al.
BMJ (2022), pp. e071249-e071249
Open Access | Times Cited: 54
Elsie Horne, William Hulme, Ruth H. Keogh, et al.
BMJ (2022), pp. e071249-e071249
Open Access | Times Cited: 54
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 421-434
Open Access | Times Cited: 52
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 421-434
Open Access | Times Cited: 52
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
Stephanie J. Schrag, Jennifer R. Verani, Brian E. Dixon, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2233273-e2233273
Open Access | Times Cited: 50
Stephanie J. Schrag, Jennifer R. Verani, Brian E. Dixon, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2233273-e2233273
Open Access | Times Cited: 50
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1603-1603
Open Access | Times Cited: 46
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1603-1603
Open Access | Times Cited: 46
COVID-19 vaccines in pregnancy
Marta C. Nunes, Shabir A. Madhi
Trends in Molecular Medicine (2022) Vol. 28, Iss. 8, pp. 662-680
Open Access | Times Cited: 45
Marta C. Nunes, Shabir A. Madhi
Trends in Molecular Medicine (2022) Vol. 28, Iss. 8, pp. 662-680
Open Access | Times Cited: 45
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2304-2314
Open Access | Times Cited: 44
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2304-2314
Open Access | Times Cited: 44
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
Yuntao Zou, Doudou Huang, Qian Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 41
Yuntao Zou, Doudou Huang, Qian Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 41
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
Rontgene Solante, Carlos Álvarez, Erlina Burhan, et al.
Expert Review of Vaccines (2022) Vol. 22, Iss. 1, pp. 1-16
Open Access | Times Cited: 41
Rontgene Solante, Carlos Álvarez, Erlina Burhan, et al.
Expert Review of Vaccines (2022) Vol. 22, Iss. 1, pp. 1-16
Open Access | Times Cited: 41